(Q42679025)

English

Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice

scientific article published on June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

author name string

DeMatos P

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Abdel-Wahab Z

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Vervaert C

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hester D

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Seigler H

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

79-91

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Adhesion Molecules CD11a, CD18, and ICAM-1 on Human Epidermal Langerhans Cells Serve a Functional Role in the Activation of Alloreactive T Cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Shared T cell epitopes in epithelial tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Immunological memory induced by genetically transduced tumor cells.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Allostimulatory cells in fresh human blood: heterogeneity in antigen-presenting cell populations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Expression of B7 costimulator molecules on mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199806%2968%3A2%3C79%3A%3AAID-JSO3%3E3.0.CO%3B2-H

21 January 2018

Identifiers

10.1002/(SICI)1096-9098(199806)68:2<79::AID-JSO3>3.0.CO;2-H

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42679025&oldid=1965246039"